Etofit Tablet ER
Marketer
Fitwel Pharmaceuticals Private Limited
Salt Composition
Etodolac (400mg)
Overview Etofit Tablet ER
RheumaSol ER tablets offer effective pain and inflammation relief. This medication is indicated for conditions including rheumatoid arthritis, osteoarthritis, and acute pain episodes. Always adhere to your physician's prescribed dosage and duration. To minimize stomach irritation, take with food or milk. Prior heart disease or stroke history should be disclosed to your doctor. Common side effects can include nausea, vomiting, indigestion, and abdominal discomfort. Dizziness, drowsiness, or visual changes may also occur. Prolonged use necessitates regular monitoring of kidney and liver function, along with blood component levels, by your doctor. Extended therapy carries a potential risk of serious complications like gastrointestinal bleeding and renal dysfunction.
Primary Ingredients of Etofit Tablet ER
No information provided. Please provide the text you wish to be rephrased.
Uses of Etofit Tablet ER
Analgesia
Major Benefits of Etofit Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Etofit Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with food.
Common Side effects of Etofit Tablet ER:
- Vomiting
- Stomach pain/epigastric pain
- Nausea
- Indigestion
- Dizziness
- Drowsiness
How to use Etofit Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Etofit ER tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
How Etofit Tablet ER works:
Etofit Extended-Release tablets contain a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and edema.
SAFETY ADVICE
AlcoholUNSAFE
Combining Etofit Tablet ER and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Prolonged-release Etofit tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Etofit tablets likely pose a risk to breastfeeding infants. Available data from humans indicate potential transfer to breast milk, potentially causing infant harm.
DrivingUNSAFE
Extended-release Etofit tablets can reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Etofit Tablet ER in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended. Routine monitoring of renal function is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Etofit Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Etofit Tablet ER :
Should you forget a dose of Etofit Tablet ER, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your normal dosing pattern. Avoid taking a double dose.
Facts to Know About Etofit Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Indole Carboxylic Acid Derivatives |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
3,018 People bought this recently